A proactive response to prescription opioid abuse

New England Journal of Medicine

Volumn 374, Issue 15, 2016, Pages 1480-1485

  Califf, Robert M ^a   Woodcock, Janet ^a   Ostroff, Stephen ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

DRUG ABUSE; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG LABELING; DRUG MISUSE; DRUG OVERDOSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HEALTH PROGRAM; HUMAN; MEDICAL DECISION MAKING; NEEDS ASSESSMENT; OPIATE ADDICTION; PAIN; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNITED STATES; ANALGESIA; DRUG CONTROL; LEGISLATION AND JURISPRUDENCE; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; PROCEDURES;

ANALGESICS, OPIOID; DRUG AND NARCOTIC CONTROL; DRUG LABELING; HUMANS; OPIOID-RELATED DISORDERS; PAIN MANAGEMENT; PRESCRIPTION DRUG MISUSE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84963818582     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsr1601307     Document Type: Review

References (13)

1. Department of Health and Human Services. HHS takes strong steps to address opioid-drug related overdose, death and dependence. March 26, 2015 (http://www.hhs.gov/about/news/2015/03/26/hhs-takes-strong-steps-to-address-opioid-drug-related-overdose-death-and-dependence.html).
2. Centers for Disease Control and Prevention. Vital signs: opioid painkiller prescribing. July 2014 (http://www.cdc.gov/vitalsigns/opioid-prescribing).
3. Food and Drug Administration. Letter to application holders: ER/LA opioid analgesic class labeling changes and postmarketing requirements (http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf).
4. Food and Drug Administration. Risk evaluation and mitigation strategy (REMS) for extended-release and long-acting opioids (http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm163647.htm).
5. Executive Office of the President of the United States. Epidemic: responding to America's prescription drug abuse crisis. 2011 (https://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx-abuse-plan.pdf).
6. Office of National Drug Control Policy. National Drug Control Strategy. 2014 (https://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs-2014.pdf).
7. Food and Drug Administration. Guidance for industry: Abusedeterrent opioids - evaluation and labeling. April 2015 (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM334743.pdf).
8. Food and Drug Administration. FDA approves new handheld auto-injector to reverse opioid overdose. April 3, 2014 (http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm).
9. Food and Drug Administration. FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose. November 18, 2015 (http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473505.htm).
10. Federal Register Notice. Proposed 2016 guideline for prescribing opioids for chronic pain (https://www.federalregister.gov/articles/2015/12/14/2015-31375/proposed-2016-guideline-for-prescribing-opioids-for-chronic-pain).
11. Office of the Surgeon General. National prevention strategy - America's plan for better health and wellness. 2011 (http://www.surgeongeneral.gov/priorities/prevention/strategy/report.pdf).
12. Eunice Kennedy Shriver National Institute of Child Health and Human Development. About the Best Pharmaceuticals for Children Act (http://bpca.nichd.nih.gov/about/Pages/Index.aspx).
13. Centers for Disease Control and Prevention. Web-based Injury Statistics Query and Reporting System (WISQARS). 2014 (http://www.cdc.gov/injury/wisqars/fatal.html).